NEPH

Nephros, Inc.

$3.15

5.00%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Source: Yahoo Finance
AI summary

Price & performance

1M-11.7%
3M-4.4%
YTD-31.8%
1Y-43.2%
52-week range—
Beta0.48
Full chart and returns against a benchmark

Q-Score

73/ 100

Quality against peers; 50 is the peer median.

Growth63
Risk48
Performance65
Valuation72
Profitability72
Leverage68
Sentiment49
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$18.8M+32.7%
Net income$1.2M+1513.5%
Net margin6.4%+5.8 pts
Historical fundamentals

Red flags in filings

1active red flag
Material weakness in controlsMar 12, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer44%
Regions, segments, customers and suppliers

Valuation

NEPHIndustryP/E17.9249.36P/S1.593.73EV/EBITDA15.2423.12P/B2.733.92PEG0.620.62
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate$0.03
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate